Related Experiment Video
Updated: Jul 17, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
[New trends in non-Hodgkin's lymphoma therapy]
Grzegorz Mazur1, Tomasz Wróbel, Wojciech Jurczak
1Katedra i Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku Akademii Medycznej we Wrocławiu. grzegorzmaz@yahoo.com
Abstract:
Non-Hodgkin's lymphomas are a heterogeneous group of lymphoid malignancies. Although great progress in the treatment of these diseases has been made in the last years, it is still difficult to achieve and sustain remission in different lymphoma subtypes and some of patients have poor prognosis. Apart from monoclonal antibodies, radioimmunotherapy, and autologous stem cell transplantation, which are used as standard therapy for some lymphomas, new drugs with different mechanism of action are currently being tested. This article describes new methods and drugs which are used in the treatment of non-Hodgkin's lymphomas.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)